SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis.
about
SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
SGLT2 inhibitor plus DPP-4 inh ...... atic review and meta-analysis.
@en
SGLT2 inhibitor plus DPP-4 inh ...... atic review and meta-analysis.
@nl
type
label
SGLT2 inhibitor plus DPP-4 inh ...... atic review and meta-analysis.
@en
SGLT2 inhibitor plus DPP-4 inh ...... atic review and meta-analysis.
@nl
prefLabel
SGLT2 inhibitor plus DPP-4 inh ...... atic review and meta-analysis.
@en
SGLT2 inhibitor plus DPP-4 inh ...... atic review and meta-analysis.
@nl
P356
P1476
SGLT2 inhibitor plus DPP-4 inh ...... matic review and meta-analysis
@en
P2093
Weilong Shi
P304
P356
10.1111/DOM.13294
P577
2018-04-14T00:00:00Z